>AT4G12460.1 | ORP2B (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2B) oxysterol binding
MPLTRSKSLPATENGGSDRETLQSGRSVAGILYKWTNYGKGWRSRWFLLRDGILSYSKIR
RPENVNLLSPSDDLRLIGDISTDRLLRMKSCSGRSRRKHHKNIGIVHLKVSSYRESKSDH
RKFYIFTATKTLHLRTDSRSDRAAWLQALASTRGIVPLQSINGDFSFVSPKDLSISTERL
KKRLFEEGMNESLVKECEQIVDSEFCEVQEQIKLLHEERKKLLDALRQLEMANLEAEASG
IHDDVYQLRNHKYSSLGRGKYSECSTSASSDDKQEFEDISEEDEASFHDTKESFGEPDVG
SVLTHFKRRTKLPDPAEKERGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLE
YSYLLDQAYEYGKSGKSLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGI
RFFSEKVSHHPTVIACHCEGKGWKFWGDTNLRSKFWGRSIQLEPVGILTLEFDDGEIFQW
SKVTTTIYNILLGKLYCDHHGIMKIRGNRQYSCMLKFKEQSILDRNPHQVNGFVEDVTGK
KAATVFGKWNDSLYYVAGDGINKASASLLWKATKAPPNVTRYNFTSFAMTLNELIPGLEE
KLPPTDSRLRPDQRHLENGEYEKANEEKQRLERRQRMSRQIQESGWRPRWFEPQGESESY
KYTGGYWEARDVKSWDDCPNIFGEFTEEVADCA*
>AT4G12460.1 | ORP2B (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2B) oxysterol binding
MPLTRSKSLPATENGGSDRETLQSGRSVAGILYKWTNYGKGWRSRWFLLRDGILSYSKIR
RPENVNLLSPSDDLRLIGDISTDRLLRMKSCSGRSRRKHHKNIGIVHLKVSSYRESKSDH
RKFYIFTATKTLHLRTDSRSDRAAWLQALASTRGIVPLQSINGDFSFVSPKDLSISTERL
KKRLFEEGMNESLVKECEQIVDSEFCEVQEQIKLLHEERKKLLDALRQLEMANLEAEASG
IHDDVYQLRNHKYSSLGRGKYSECSTSASSDDKQEFEDISEEDEASFHDTKESFGEPDVG
SVLTHFKRRTKLPDPAEKERGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLE
YSYLLDQAYEYGKSGKSLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGI
RFFSEKVSHHPTVIACHCEGKGWKFWGDTNLRSKFWGRSIQLEPVGILTLEFDDGEIFQW
SKVTTTIYNILLGKLYCDHHGIMKIRGNRQYSCMLKFKEQSILDRNPHQVNGFVEDVTGK
KAATVFGKWNDSLYYVAGDGINKASASLLWKATKAPPNVTRYNFTSFAMTLNELIPGLEE
KLPPTDSRLRPDQRHLENGEYEKANEEKQRLERRQRMSRQIQESGWRPRWFEPQGESESY
KYTGGYWEARDVKSWDDCPNIFGEFTEEVADCA*
>AT4G12460.2 | ORP2B (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2B) oxysterol binding
MIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDQAYEYGKSGKSLLRALNVAA
FAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHHPTVIACHCEGKGWKFW
GDTNLRSKFWGRSIQLEPVGILTLEFDDGEIFQWSKVTTTIYNILLGKLYCDHHGIMKIR
GNRQYSCMLKFKEQSILDRNPHQVNGFVEDVTGKKAATVFGKWNDSLYYVAGDGINKASA
SLLWKATKAPPNVTRYNFTSFAMTLNELIPGLELPPTDSRLRPDQRHLENGEYEKANEEK
QRLERRQRMSRQIQESGWRPRWFEPQGESESYKYTGGYWEARDVKSWDDCPNIFGEFTEE
VADCA*
>AT4G12460.2 | ORP2B (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2B) oxysterol binding
MIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDQAYEYGKSGKSLLRALNVAA
FAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHHPTVIACHCEGKGWKFW
GDTNLRSKFWGRSIQLEPVGILTLEFDDGEIFQWSKVTTTIYNILLGKLYCDHHGIMKIR
GNRQYSCMLKFKEQSILDRNPHQVNGFVEDVTGKKAATVFGKWNDSLYYVAGDGINKASA
SLLWKATKAPPNVTRYNFTSFAMTLNELIPGLELPPTDSRLRPDQRHLENGEYEKANEEK
QRLERRQRMSRQIQESGWRPRWFEPQGESESYKYTGGYWEARDVKSWDDCPNIFGEFTEE
VADCA*
>AT2G17360.1 | 40S ribosomal protein S4 (RPS4A)
MARGLKKHLKRLNAPKHWMLDKLGGAFAPKPSSGPHKSRECLPLVLIIRNRLKYALTYRE
VISILMQRHIQVDGKVRTDKTYPAGFMDVVSIPKTNENFRLLYDTKGRFRLHSIKDEEAK
FKLCKVRSIQFGQKGIPYLNTYDGRTIRYPDPLIKPNDTIKLDLEENKIVEFIKFDVGNV
VMVTGGRNRGRVGVIKNREKHKGSFETIHIQDSTGHEFATRLGNVYTIGKGTKPWVSLPK
GKGIKLTIIEEARKRLSAQQA*
>AT2G45200.1 | GOS12 (GOLGI SNARE 12) SNARE binding
MTESSLDLQESGWEELRREARKIEGDLDVKLSSYAKLGARFTQGGYVDTGSPTVGSGRSW
KSMEMEIQSLLEKLLDINDSMSRCAASAAPTTSVTQKLARHRDILHEYTQEFRRIKGNIN
SLREHAELLSSVRDDISEYKASGSMSPGVQVLRERASIHGSISHIDDVIGQAQATRAVLG
SQRSLFSDVQGKVKNLGDKFPVIRGLLGSIKRKRSRDTLILSAVIAACTLFLIIYWLSK*
>AT5G23670.1 | LCB2 protein binding / serine C-palmitoyltransferase
MITIPYLTAVSTYFSYGLLFAFGQLRDFFRRFIDWWFTSNLQGYAPICLGHEDFYIRRLY
HRIQDCFERPISSAPDAWFDVVERYSNDNNKTLKRTTKTSRCLNLGSYNYLGFGSFDEYC
TPRVIESLKKFSASTCSSRVDAGTTSVHAELEECVTRFVGKPAAVVFGMGYATNSAIIPV
LIGKGGLIISDSLNHSSIVNGARGSGATIRVFQHNTPSHLERVLREQIAEGQPRTHRPWK
KIIVVVEGIYSMEGEICHLPEVVAICKKYKAYVYLDEAHSIGAIGKTGKGICELLGVDTA
DVDVMMGTFTKSFGSCGGYIAGSKELIQYLKHQCPAHLYATSIPTPSAQQIISAIKVILG
EDGSNRGAQKLARIRENSNFFRAELQKMGFEVLGDNDSPVMPIMLYNPAKIPAFSRECLR
QKVAVVVVGFPATPLLLARARICISASHSREDLIRALKVISKVGDLSGIKYFPAEPKKIE
QSKNDIKLD*
>AT5G23670.1 | LCB2 protein binding / serine C-palmitoyltransferase
MITIPYLTAVSTYFSYGLLFAFGQLRDFFRRFIDWWFTSNLQGYAPICLGHEDFYIRRLY
HRIQDCFERPISSAPDAWFDVVERYSNDNNKTLKRTTKTSRCLNLGSYNYLGFGSFDEYC
TPRVIESLKKFSASTCSSRVDAGTTSVHAELEECVTRFVGKPAAVVFGMGYATNSAIIPV
LIGKGGLIISDSLNHSSIVNGARGSGATIRVFQHNTPSHLERVLREQIAEGQPRTHRPWK
KIIVVVEGIYSMEGEICHLPEVVAICKKYKAYVYLDEAHSIGAIGKTGKGICELLGVDTA
DVDVMMGTFTKSFGSCGGYIAGSKELIQYLKHQCPAHLYATSIPTPSAQQIISAIKVILG
EDGSNRGAQKLARIRENSNFFRAELQKMGFEVLGDNDSPVMPIMLYNPAKIPAFSRECLR
QKVAVVVVGFPATPLLLARARICISASHSREDLIRALKVISKVGDLSGIKYFPAEPKKIE
QSKNDIKLD*
>AT5G23670.2 | LCB2 protein binding / serine C-palmitoyltransferase
MITIPYLTAVSTYFSYGLLFAFGQLRDFFRRFIDWWFTSNLQGYAPICLGHEDFYIRRLY
HRIQDCFERPISSAPDAWFDVVERYSNDNNKTLKRTTKTSRCLNLGSYNYLGFGSFDEYC
TPRVIESLKKFSASTCSSRVDAGTTSVHAELEECVTRFVGKPAAVVFGMGYATNSAIIPV
LIGKGGLIISDSLNHSSIVNGARGSGATIRVFQHNTPSHLERVLREQIAEGQPRTHRPWK
KIIVVVEGIYSMEGEICHLPEVVAICKKYKAYVYLDEAHSIGAIGKTGKGICELLGVDTA
DVDVMMGTFTKSFGSCGGYIAGSKELIQYLKHQCPAHLYATSIPTPSAQQIISAIKVILG
EDGSNRGAQKLARIRENSNFFRAELQKMGFEVLGDNDSPVMPIMLYNPAKIPAFSRECLR
QKVAVVVVGFPATPLLLARARICISASHSREDLIRALKVISKVGDLSGIKYFPAEPKKIE
QSKNDIKLD*
>AT5G23670.2 | LCB2 protein binding / serine C-palmitoyltransferase
MITIPYLTAVSTYFSYGLLFAFGQLRDFFRRFIDWWFTSNLQGYAPICLGHEDFYIRRLY
HRIQDCFERPISSAPDAWFDVVERYSNDNNKTLKRTTKTSRCLNLGSYNYLGFGSFDEYC
TPRVIESLKKFSASTCSSRVDAGTTSVHAELEECVTRFVGKPAAVVFGMGYATNSAIIPV
LIGKGGLIISDSLNHSSIVNGARGSGATIRVFQHNTPSHLERVLREQIAEGQPRTHRPWK
KIIVVVEGIYSMEGEICHLPEVVAICKKYKAYVYLDEAHSIGAIGKTGKGICELLGVDTA
DVDVMMGTFTKSFGSCGGYIAGSKELIQYLKHQCPAHLYATSIPTPSAQQIISAIKVILG
EDGSNRGAQKLARIRENSNFFRAELQKMGFEVLGDNDSPVMPIMLYNPAKIPAFSRECLR
QKVAVVVVGFPATPLLLARARICISASHSREDLIRALKVISKVGDLSGIKYFPAEPKKIE
QSKNDIKLD*
>AT5G25780.1 | EIF3B-2 (EUKARYOTIC TRANSLATION INITIATION FACTOR 3B-2) nucleic acid binding / protein binding / translation initiation factor
MAAVVDIDVLTAQLGINWSDVNLDSIQLPPGNDFGIESDDESVYQDDQSEFDTGFGNIIV
VDHLPVVPKEKFEKLEGVVKKIYNQLGVIKENGLLMPVDPDTKMTLGYCFIEFNTPQEAQ
NAKEKSHGYKLDKSHIFAVNMFDDFDRLMNVKEEWEPPQERPYVPGENLQKWLTDDKARD
QLVIRFGHDTEVYWNDARQKKPEPVHKRSYWTESYVQWSPIGTYLVTLHKQGAAVWGGAD
TFTRLMRYQHSMVKLVDFSPGEKYLVTYHSQEPSNPRDASKVEIKVFDVRTGRMMRDFKG
SADEFSIGGPGGVAGASWPVFRWAGGKDDKYFAKLSKNTISVYETETFSLIDKKSMKVDN
VVDICWSPTDSILSLFVPEQGGGNQPAKVALVQIPSKVELRQKNLFSVSDCKMYWQSSGE
YLAVKVDRYTKTKKSTYSGFELFRIKERDIPIEVLELDNKNDKIIAFAWEPKGHRFAVIH
GDQPRPDVSFYSMKTAQNTGRVSKLATLKAKQANALFWSPTGKYIILAGLKGFNGQLEFF
NVDELETMATAEHFMATDIEWDPTGRYVATSVTTVHEMENGFTIWSFNGNMVYRILKDHF
FQLAWRPRPASFLTAEKEEEIAKNLRNYSKRYEAEDQDVSLLLSEQDREKRRALNEEWQK
WVMQWKSLHEEEKLVRQNLRDGEVSDVEEDEYEAKEVEFEDLIDVTEEIVQELM*
>AT1G13440.1 | GAPC2 (GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE C2) NAD or NADH binding / binding / catalytic/ glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)/ glyceraldehyde-3-phosphate dehydrogenase
MADKKIRIGINGFGRIGRLVARVVLQRDDVELVAVNDPFITTEYMTYMFKYDSVHGQWKH
HELKVKDDKTLLFGEKPVTVFGIRNPEDIPWGEAGADFVVESTGVFTDKDKAAAHLKGGA
KKVVISAPSKDAPMFVVGVNEHEYKSDLDIVSNASCTTNCLAPLAKVINDRFGIVEGLMT
TVHSITATQKTVDGPSMKDWRGGRAASFNIIPSSTGAAKAVGKVLPSLNGKLTGMSFRVP
TVDVSVVDLTVRLEKAATYDEIKKAIKEESEGKMKGILGYTEDDVVSTDFVGDNRSSIFD
AKAGIALSDKFVKLVSWYDNEWGYSSRVVDLIVHMSKA*
>AT1G13440.1 | GAPC2 (GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE C2) NAD or NADH binding / binding / catalytic/ glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)/ glyceraldehyde-3-phosphate dehydrogenase
MADKKIRIGINGFGRIGRLVARVVLQRDDVELVAVNDPFITTEYMTYMFKYDSVHGQWKH
HELKVKDDKTLLFGEKPVTVFGIRNPEDIPWGEAGADFVVESTGVFTDKDKAAAHLKGGA
KKVVISAPSKDAPMFVVGVNEHEYKSDLDIVSNASCTTNCLAPLAKVINDRFGIVEGLMT
TVHSITATQKTVDGPSMKDWRGGRAASFNIIPSSTGAAKAVGKVLPSLNGKLTGMSFRVP
TVDVSVVDLTVRLEKAATYDEIKKAIKEESEGKMKGILGYTEDDVVSTDFVGDNRSSIFD
AKAGIALSDKFVKLVSWYDNEWGYSSRVVDLIVHMSKA*
>AT1G13440.2 | GAPC2 (GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE C2) NAD or NADH binding / binding / catalytic/ glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)/ glyceraldehyde-3-phosphate dehydrogenase
MADKKIRIGINGFGRIGRLVARVVLQRDDVELVAVNDPFITTEYMTYMFKYDSVHGQWKH
HELKVKDDKTLLFGEKPVTVFGIRNPEDIPWGEAGADFVVESTGVFTDKDKAAAHLKGGA
KKVVISAPSKDAPMFVVGVNEHEFGIVEGLMTTVHSITATQKTVDGPSMKDWRGGRAASF
NIIPSSTGAAKAVGKVLPSLNGKLTGMSFRVPTVDVSVVDLTVRLEKAATYDEIKKAIKE
ESEGKMKGILGYTEDDVVSTDFVGDNRSSIFDAKAGIALSDKFVKLVSWYDNEWGYSSRV
VDLIVHMSKA*
>AT1G13440.2 | GAPC2 (GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE C2) NAD or NADH binding / binding / catalytic/ glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)/ glyceraldehyde-3-phosphate dehydrogenase
MADKKIRIGINGFGRIGRLVARVVLQRDDVELVAVNDPFITTEYMTYMFKYDSVHGQWKH
HELKVKDDKTLLFGEKPVTVFGIRNPEDIPWGEAGADFVVESTGVFTDKDKAAAHLKGGA
KKVVISAPSKDAPMFVVGVNEHEFGIVEGLMTTVHSITATQKTVDGPSMKDWRGGRAASF
NIIPSSTGAAKAVGKVLPSLNGKLTGMSFRVPTVDVSVVDLTVRLEKAATYDEIKKAIKE
ESEGKMKGILGYTEDDVVSTDFVGDNRSSIFDAKAGIALSDKFVKLVSWYDNEWGYSSRV
VDLIVHMSKA*
>AT5G10450.1 | GRF6 (G-box regulating factor 6) protein binding / protein phosphorylated amino acid binding
MAATLGRDQYVYMAKLAEQAERYEEMVQFMEQLVTGATPAEELTVEERNLLSVAYKNVIG
SLRAAWRIVSSIEQKEESRKNDEHVSLVKDYRSKVESELSSVCSGILKLLDSHLIPSAGA
SESKVFYLKMKGDYHRYMAEFKSGDERKTAAEDTMLAYKAAQDIAAADMAPTHPIRLGLA
LNFSVFYYEILNSSDKACNMAKQAFEEAIAELDTLGEESYKDSTLIMQLLRDNLTLWTSD
MQEQMDEA*
>AT5G10450.1 | GRF6 (G-box regulating factor 6) protein binding / protein phosphorylated amino acid binding
MAATLGRDQYVYMAKLAEQAERYEEMVQFMEQLVTGATPAEELTVEERNLLSVAYKNVIG
SLRAAWRIVSSIEQKEESRKNDEHVSLVKDYRSKVESELSSVCSGILKLLDSHLIPSAGA
SESKVFYLKMKGDYHRYMAEFKSGDERKTAAEDTMLAYKAAQDIAAADMAPTHPIRLGLA
LNFSVFYYEILNSSDKACNMAKQAFEEAIAELDTLGEESYKDSTLIMQLLRDNLTLWTSD
MQEQMDEA*
>AT5G10450.2 | GRF6 (G-box regulating factor 6) protein binding / protein phosphorylated amino acid binding
MAATLGRDQYVYMAKLAEQAERYEEMVQFMEQLVTGATPAEELTVEERNLLSVAYKNVIG
SLRAAWRIVSSIEQKEESRKNDEHVSLVKDYRSKVESELSSVCSGILKLLDSHLIPSAGA
SESKVFYLKMKGDYHRYMAEFKSGDERKTAAEDTMLAYKAAQDIAAADMAPTHPIRLGLA
LNFSVFYYEILNSSDKACNMAKQAFEEAIAELDTLGEESYKDSTLIMQLLRDNLTLWTSD
MQMDEA*
>AT5G10450.2 | GRF6 (G-box regulating factor 6) protein binding / protein phosphorylated amino acid binding
MAATLGRDQYVYMAKLAEQAERYEEMVQFMEQLVTGATPAEELTVEERNLLSVAYKNVIG
SLRAAWRIVSSIEQKEESRKNDEHVSLVKDYRSKVESELSSVCSGILKLLDSHLIPSAGA
SESKVFYLKMKGDYHRYMAEFKSGDERKTAAEDTMLAYKAAQDIAAADMAPTHPIRLGLA
LNFSVFYYEILNSSDKACNMAKQAFEEAIAELDTLGEESYKDSTLIMQLLRDNLTLWTSD
MQMDEA*
>AT4G34200.1 | EDA9 (embryo sac development arrest 9) ATP binding
MSATAAASSSIAVATNSLRNVTLSSRSPLPSAISVAFPSRGRNTLQRRLVLVSCSTGDGS
KPTILVAEKLGDAGIKLLEDVANVDCSYNMTPEELNIKISLCDALIVRSGTKVGREVFES
SHGRLKVVGRAGVGIDNVDLSAATEFGCLVVNAPTANTIAAAEHGIALMAAMARNVAQAD
ASVKAGEWKRNKYVGVSLVGKTLAVLGFGKVGTEVARRAKGLGMRVIAHDPYAPADRAHA
IGVDLVSFDEALATADFISLHMPLTPTTSKILNDETFAKMKKGVRIVNVARGGVIDEDAL
VRALDAGIVAQAALDVFTKEPPAKDSKLVQHERVTVTPHLGASTMEAQEGVAIEIAEAVV
GALNGELAATAVNAPMVSAEVLTELKPYVVLAEKLGRLAVQLVAGGSGVKNAKITYASAR
ATDDLDTRLLRAMITKGIIEPISDVYVNLVNADFTAKQRGLRLSEERVLLDGSPESPLET
ITVQLSNVESKFASSLSESGEVKVEGKVKDGVPHLTKVGSFEVDVTLEGSIILCRQVDQP
GMIGTVGSILGESNVNVNFMSVGRIAPRKQAIMAIGVDDIPSKETLKKIGEIPAVEEFVF
LKL*
>AT5G60390.1 | elongation factor 1-alpha / EF-1-alpha
MGKEKFHINIVVIGHVDSGKSTTTGHLIYKLGGIDKRVIERFEKEAAEMNKRSFKYAWVL
DKLKAERERGITIDIALWKFETTKYYCTVIDAPGHRDFIKNMITGTSQADCAVLIIDSTT
GGFEAGISKDGQTREHALLAFTLGVKQMICCCNKMDATTPKYSKARYDEIIKEVSSYLKK
VGYNPDKIPFVPISGFEGDNMIERSTNLDWYKGPTLLEALDQINEPKRPSDKPLRLPLQD
VYKIGGIGTVPVGRVETGMIKPGMVVTFAPTGLTTEVKSVEMHHESLLEALPGDNVGFNV
KNVAVKDLKRGYVASNSKDDPAKGAANFTSQVIIMNHPGQIGNGYAPVLDCHTSHIAVKF
SEILTKIDRRSGKEIEKEPKFLKNGDAGMVKMTPTKPMVVETFSEYPPLGRFAVRDMRQT
VAVGVIKSVDKKDPTGAKVTKAAVKKGAK*
>AT5G60390.1 | elongation factor 1-alpha / EF-1-alpha
MGKEKFHINIVVIGHVDSGKSTTTGHLIYKLGGIDKRVIERFEKEAAEMNKRSFKYAWVL
DKLKAERERGITIDIALWKFETTKYYCTVIDAPGHRDFIKNMITGTSQADCAVLIIDSTT
GGFEAGISKDGQTREHALLAFTLGVKQMICCCNKMDATTPKYSKARYDEIIKEVSSYLKK
VGYNPDKIPFVPISGFEGDNMIERSTNLDWYKGPTLLEALDQINEPKRPSDKPLRLPLQD
VYKIGGIGTVPVGRVETGMIKPGMVVTFAPTGLTTEVKSVEMHHESLLEALPGDNVGFNV
KNVAVKDLKRGYVASNSKDDPAKGAANFTSQVIIMNHPGQIGNGYAPVLDCHTSHIAVKF
SEILTKIDRRSGKEIEKEPKFLKNGDAGMVKMTPTKPMVVETFSEYPPLGRFAVRDMRQT
VAVGVIKSVDKKDPTGAKVTKAAVKKGAK*
>AT5G60390.1 | elongation factor 1-alpha / EF-1-alpha
MGKEKFHINIVVIGHVDSGKSTTTGHLIYKLGGIDKRVIERFEKEAAEMNKRSFKYAWVL
DKLKAERERGITIDIALWKFETTKYYCTVIDAPGHRDFIKNMITGTSQADCAVLIIDSTT
GGFEAGISKDGQTREHALLAFTLGVKQMICCCNKMDATTPKYSKARYDEIIKEVSSYLKK
VGYNPDKIPFVPISGFEGDNMIERSTNLDWYKGPTLLEALDQINEPKRPSDKPLRLPLQD
VYKIGGIGTVPVGRVETGMIKPGMVVTFAPTGLTTEVKSVEMHHESLLEALPGDNVGFNV
KNVAVKDLKRGYVASNSKDDPAKGAANFTSQVIIMNHPGQIGNGYAPVLDCHTSHIAVKF
SEILTKIDRRSGKEIEKEPKFLKNGDAGMVKMTPTKPMVVETFSEYPPLGRFAVRDMRQT
VAVGVIKSVDKKDPTGAKVTKAAVKKGAK*
>AT5G60390.2 | elongation factor 1-alpha / EF-1-alpha
MGKEKFHINIVVIGHVDSGKSTTTGHLIYKLGGIDKRVIERFEKEAAEMNKRSFKYAWVL
DKLKAERERGITIDIALWKFETTKYYCTVIDAPGHRDFIKNMITGTSQADCAVLIIDSTT
GGFEAGISKDGQTREHALLAFTLGVKQMICCCNKMDATTPKYSKARYDEIIKEVSSYLKK
VGYNPDKIPFVPISGFEGDNMIERSTNLDWYKGPTLLEALDQINEPKRPSDKPLRLPLQD
VYKIGGIGTVPVGRVETGMIKPGMVVTFAPTGLTTEVKSVEMHHESLLEALPGDNVGFNV
KNVAVKDLKRGYVASNSKDDPAKGAANFTSQVIIMNHPGQIGNGYAPVLDCHTSHIAVKF
SEILTKIDRRSGKEIEKEPNPWLLRLSPSTHLWDVSLLGT*
>AT5G60390.2 | elongation factor 1-alpha / EF-1-alpha
MGKEKFHINIVVIGHVDSGKSTTTGHLIYKLGGIDKRVIERFEKEAAEMNKRSFKYAWVL
DKLKAERERGITIDIALWKFETTKYYCTVIDAPGHRDFIKNMITGTSQADCAVLIIDSTT
GGFEAGISKDGQTREHALLAFTLGVKQMICCCNKMDATTPKYSKARYDEIIKEVSSYLKK
VGYNPDKIPFVPISGFEGDNMIERSTNLDWYKGPTLLEALDQINEPKRPSDKPLRLPLQD
VYKIGGIGTVPVGRVETGMIKPGMVVTFAPTGLTTEVKSVEMHHESLLEALPGDNVGFNV
KNVAVKDLKRGYVASNSKDDPAKGAANFTSQVIIMNHPGQIGNGYAPVLDCHTSHIAVKF
SEILTKIDRRSGKEIEKEPNPWLLRLSPSTHLWDVSLLGT*
>AT5G60390.2 | elongation factor 1-alpha / EF-1-alpha
MGKEKFHINIVVIGHVDSGKSTTTGHLIYKLGGIDKRVIERFEKEAAEMNKRSFKYAWVL
DKLKAERERGITIDIALWKFETTKYYCTVIDAPGHRDFIKNMITGTSQADCAVLIIDSTT
GGFEAGISKDGQTREHALLAFTLGVKQMICCCNKMDATTPKYSKARYDEIIKEVSSYLKK
VGYNPDKIPFVPISGFEGDNMIERSTNLDWYKGPTLLEALDQINEPKRPSDKPLRLPLQD
VYKIGGIGTVPVGRVETGMIKPGMVVTFAPTGLTTEVKSVEMHHESLLEALPGDNVGFNV
KNVAVKDLKRGYVASNSKDDPAKGAANFTSQVIIMNHPGQIGNGYAPVLDCHTSHIAVKF
SEILTKIDRRSGKEIEKEPNPWLLRLSPSTHLWDVSLLGT*
>AT5G60390.3 | elongation factor 1-alpha / EF-1-alpha
MGKEKFHINIVVIGHVDSGKSTTTGHLIYKLGGIDKRVIERFEKEAAEMNKRSFKYAWVL
DKLKAERERGITIDIALWKFETTKYYCTVIDAPGHRDFIKNMITGTSQADCAVLIIDSTT
GGFEAGISKDGQTREHALLAFTLGVKQMICCCNKMDATTPKYSKARYDEIIKEVSSYLKK
VGYNPDKIPFVPISGFEGDNMIERSTNLDWYKGPTLLEALDQINEPKRPSDKPLRLPLQD
VYKIGGIGTVPVGRVETGMIKPGMVVTFAPTGLTTEVKSVEMHHESLLEALPGDNVGFNV
KNVAVKDLKRGYVASNSKDDPAKGAANFTSQVIIMNHPGQIGNGYAPVLDCHTSHIAVKF
SEILTKIDRRSGKEIEKEPKFLKNGDAGMVKMTPTKPMVVETFSEYPPLGRFAVRDMRQT
VAVGVIKSVDKKDPTGAKVTKAAVKKGAK*
>AT5G60390.3 | elongation factor 1-alpha / EF-1-alpha
MGKEKFHINIVVIGHVDSGKSTTTGHLIYKLGGIDKRVIERFEKEAAEMNKRSFKYAWVL
DKLKAERERGITIDIALWKFETTKYYCTVIDAPGHRDFIKNMITGTSQADCAVLIIDSTT
GGFEAGISKDGQTREHALLAFTLGVKQMICCCNKMDATTPKYSKARYDEIIKEVSSYLKK
VGYNPDKIPFVPISGFEGDNMIERSTNLDWYKGPTLLEALDQINEPKRPSDKPLRLPLQD
VYKIGGIGTVPVGRVETGMIKPGMVVTFAPTGLTTEVKSVEMHHESLLEALPGDNVGFNV
KNVAVKDLKRGYVASNSKDDPAKGAANFTSQVIIMNHPGQIGNGYAPVLDCHTSHIAVKF
SEILTKIDRRSGKEIEKEPKFLKNGDAGMVKMTPTKPMVVETFSEYPPLGRFAVRDMRQT
VAVGVIKSVDKKDPTGAKVTKAAVKKGAK*
>AT5G60390.3 | elongation factor 1-alpha / EF-1-alpha
MGKEKFHINIVVIGHVDSGKSTTTGHLIYKLGGIDKRVIERFEKEAAEMNKRSFKYAWVL
DKLKAERERGITIDIALWKFETTKYYCTVIDAPGHRDFIKNMITGTSQADCAVLIIDSTT
GGFEAGISKDGQTREHALLAFTLGVKQMICCCNKMDATTPKYSKARYDEIIKEVSSYLKK
VGYNPDKIPFVPISGFEGDNMIERSTNLDWYKGPTLLEALDQINEPKRPSDKPLRLPLQD
VYKIGGIGTVPVGRVETGMIKPGMVVTFAPTGLTTEVKSVEMHHESLLEALPGDNVGFNV
KNVAVKDLKRGYVASNSKDDPAKGAANFTSQVIIMNHPGQIGNGYAPVLDCHTSHIAVKF
SEILTKIDRRSGKEIEKEPKFLKNGDAGMVKMTPTKPMVVETFSEYPPLGRFAVRDMRQT
VAVGVIKSVDKKDPTGAKVTKAAVKKGAK*
>AT1G59820.1 | ALA3 (Aminophospholipid ATPase3) ATPase coupled to transmembrane movement of ions phosphorylative mechanism / phospholipid transporter
MVRSGSFSVDSSATHQRTPSRTVTLGHIQPQAPTYRTVYCNDRESNQPVRFKGNSISTTK
YNVFTFLPKGLFEQFRRIANIYFLGISCLSMTPISPVSPITNVAPLSMVLLVSLIKEAFE
DWKRFQNDMSINNSTVEILQDQQWVSIPWRKLQVGDIVKIKKDGFFPADILFMSSTNSDG
ICYVETANLDGETNLKIRKALERTWDYLVPEKAYEFKGEIQCEQPNNSLYTFTGNLVVQK
QTLPLSPDQLLLRGCSLRNTEYIVGAVVFTGHETKVMMNAMNAPSKRSTLEKKLDKLIIT
IFCVLVTMCLIGAIGCSIVTDREDKYLGLHNSDWEYRNGLMIGFFTFFTLVTLFSSIIPI
SLYVSIEMIKFIQSTQFINRDLNMYHAETNTPASARTSNLNEELGQVEYIFSDKTGTLTR
NLMEFFKCSIGGVSYGCGVTEIEKGIAQRHGLKVQEEQRSTGAIREKGFNFDDPRLMRGA
WRNEPNPDLCKELFRCLAICHTVLPEGDESPEKIVYQAASPDEAALVTAAKNFGFFFYRR
TPTMVYVRESHVEKMGKIQDVAYEILNVLEFNSTRKRQSVVCRFPDGRLVLYCKGADNVI
FERLANGMDDVRKVTREHLEHFGSSGLRTLCLAYKDLNPETYDSWNEKFIQAKSALRDRE
KKLDEVAELIEKDLILIGSTAIEDKLQEGVPTCIETLSRAGIKIWVLTGDKMETAINIAY
ACNLINNEMKQFVISSETDAIREAEERGDQVEIARVIKEEVKRELKKSLEEAQHSLHTVA
GPKLSLVIDGKCLMYALDPSLRVMLLSLSLNCTSVVCCRVSPLQKAQVTSLVRKGAQKIT
LSIGDGANDVSMIQAAHVGIGISGMEGMQAVMASDFAIAQFRFLTDLLLVHGRWSYLRIC
KVVMYFFYKNLTFTLTQFWFTFRTGFSGQRFYDDWFQSLFNVVFTALPVIVLGLFEKDVS
ASLSKRYPELYREGIRNSFFKWRVVAVWATSAVYQSLVCYLFVTTSSFGAVNSSGKVFGL
WDVSTMVFTCLVIAVNVRILLMSNSITRWHYITVGGSILAWLVFAFVYCGIMTPHDRNEN
VYFVIYVLMSTFYFYFTLLLVPIVSLLGDFIFQGVERWFFPYDYQIVQEIHRHESDASKA
DQLEVENELTPQEARSYAISQLPRELSKHTGFAFDSPGYESFFASQLGIYAPQKAWDVAR
RASMRSRPKVPKK*
>AT5G52640.1 | ATHSP901 (HEAT SHOCK PROTEIN 901) ATP binding / unfolded protein binding
MADVQMADAETFAFQAEINQLLSLIINTFYSNKEIFLRELISNSSDALDKIRFESLTDKS
KLDGQPELFIRLVPDKSNKTLSIIDSGIGMTKADLVNNLGTIARSGTKEFMEALQAGADV
SMIGQFGVGFYSAYLVAEKVVVTTKHNDDEQYVWESQAGGSFTVTRDVDGEPLGRGTKIT
LFLKDDQLEYLEERRLKDLVKKHSEFISYPIYLWTEKTTEKEISDDEDEDEPKKENEGEV
EEVDEEKEKDGKKKKKIKEVSHEWELINKQKPIWLRKPEEITKEEYAAFYKSLTNDWEDH
LAVKHFSVEGQLEFKAILFVPKRAPFDLFDTRKKLNNIKLYVRRVFIMDNCEELIPEYLS
FVKGVVDSDDLPLNISRETLQQNKILKVIRKNLVKKCIEMFNEIAENKEDYTKFYEAFSK
NLKLGIHEDSQNRGKIADLLRYHSTKSGDEMTSFKDYVTRMKEGQKDIFYITGESKKAVE
NSPFLERLKKRGYEVLYMVDAIDEYAVGQLKEYDGKKLVSATKEGLKLEDETEEEKKKRE
EKKKSFENLCKTIKEILGDKVEKVVVSDRIVDSPCCLVTGEYGWTANMERIMKAQALRDS
SMSGYMSSKKTMEINPDNGIMEELRKRAEADKNDKSVKDLVMLLYETALLTSGFSLDEPN
TFAARIHRMLKLGLSIDEDENVEEDGDMPELEEDAAEESKMEEVD*
>AT1G08820.1 | VAP27-2 (VAMP/SYNAPTOBREVIN-ASSOCIATED PROTEIN 27-2) structural molecule
MNMPLLDIQPRTLQFAVDLKKQTSCVVQLTNTTHHYVAFKVKTTSPKKYCVRPNVGVVAP
KSTCEFTVIMQAFKEPPPDMVCKDKFLIQSTAVSAETTDEDITASMFSKAEGKHIEENKL
RVTLVPPSDSPELSPINTPKQGAVFEDSILKDRLYSQSETLAPPQYEGEIVKEPRMVGHD
ELKAADNAKELKTPKMATVDFVEDRYTANDLKATKDSYDSSRMAKETGFDPIRSHKDADD
GRAIKATTNLDAPMKKAMDLPRDQGFTNGIAVDSEPKISKERDVVQLQKTDGQNVRGLDE
LKLVKDIEEMKLKVDALESKLKQADSTISKLMEERSISSQHRQSLQHELAELRTKKIVKE
VHNGFPLLYVCVVAFIAYVIGHFLRT*
>AT1G08820.1 | VAP27-2 (VAMP/SYNAPTOBREVIN-ASSOCIATED PROTEIN 27-2) structural molecule
MNMPLLDIQPRTLQFAVDLKKQTSCVVQLTNTTHHYVAFKVKTTSPKKYCVRPNVGVVAP
KSTCEFTVIMQAFKEPPPDMVCKDKFLIQSTAVSAETTDEDITASMFSKAEGKHIEENKL
RVTLVPPSDSPELSPINTPKQGAVFEDSILKDRLYSQSETLAPPQYEGEIVKEPRMVGHD
ELKAADNAKELKTPKMATVDFVEDRYTANDLKATKDSYDSSRMAKETGFDPIRSHKDADD
GRAIKATTNLDAPMKKAMDLPRDQGFTNGIAVDSEPKISKERDVVQLQKTDGQNVRGLDE
LKLVKDIEEMKLKVDALESKLKQADSTISKLMEERSISSQHRQSLQHELAELRTKKIVKE
VHNGFPLLYVCVVAFIAYVIGHFLRT*
>AT1G08820.2 | VAP27-2 (VAMP/SYNAPTOBREVIN-ASSOCIATED PROTEIN 27-2) structural molecule
MNMPLLDIQPRTLQFAVDLKKQTSCVVQLTNTTHHYVAFKVKTTSPKKYCVRPNVGVVAP
KSTCEFTVIMQAFKEPPPDMVCKDKFLIQSTAVSAETTDEDITASMFSKAEGKHIEENKL
RVTLVPPSDSPELSPINTPKQGAVFEDSILKDRLYSQSETLAPPQYEGEIVKEPRMVGHD
ELKAADNAKELKTPKMATVDFVEDRYTANDLKATKDSYDSSRMAKETGFDPIRSHKDADD
GRAIKATTNLDAPMKKAMDLPRDQGFTNGIAVDSEPKISKERDVVQLQKTDGQNVRGLDE
LKLVKDIEEMKLKVDALESKLKQADSTISKLMEERSISSQHRQSLQHELAELRTKKIVKE
VHNGFPLLYVCVVAFIAYVIGHFLRT*
>AT1G08820.2 | VAP27-2 (VAMP/SYNAPTOBREVIN-ASSOCIATED PROTEIN 27-2) structural molecule
MNMPLLDIQPRTLQFAVDLKKQTSCVVQLTNTTHHYVAFKVKTTSPKKYCVRPNVGVVAP
KSTCEFTVIMQAFKEPPPDMVCKDKFLIQSTAVSAETTDEDITASMFSKAEGKHIEENKL
RVTLVPPSDSPELSPINTPKQGAVFEDSILKDRLYSQSETLAPPQYEGEIVKEPRMVGHD
ELKAADNAKELKTPKMATVDFVEDRYTANDLKATKDSYDSSRMAKETGFDPIRSHKDADD
GRAIKATTNLDAPMKKAMDLPRDQGFTNGIAVDSEPKISKERDVVQLQKTDGQNVRGLDE
LKLVKDIEEMKLKVDALESKLKQADSTISKLMEERSISSQHRQSLQHELAELRTKKIVKE
VHNGFPLLYVCVVAFIAYVIGHFLRT*
>AT4G35020.1 | ARAC3 (ARABIDOPSIS RAC-LIKE 3) GTP binding / GTPase
MSASRFIKCVTVGDGAVGKTCLLISYTSNTFPTDYVPTVFDNFSANVIVDGNTINLGLWD
TAGQEDYNRLRPLSYRGADVFLLAFSLVSKASYENVSKKWVPELRHYAPGVPIILVGTKL
DLRDDKQFFAEHPGAVPISTAQGEELKKLIGAPAYIECSAKTQQNVKAVFDAAIKVVLQP
PKNKKKKKRKSQKGCSIL*
>AT5G54110.1 | ATMAMI (ARABIDOPSIS THALIANA MEMBRANE-ASSOCIATED MANNITOL-INDUCED) structural molecule
MPIGDRQNPSVEKKKNLFRLCPFWQRRSTTSSSSTQNPNQNYRSRHGNRNTDISAVSKPP
LTMSSVARSLLPARRRLRLDPSSYLYFPYEPGKQVRSAIKLKNTSKSHTAFKFQTTAPKS
CYMRPPGGVLAPGESVFATVFKFVEHPENNEKQPLNQKSKVKFKIMSLKVKPGVEYVPEL
FDEQKDQVAVEQVLRVIFIDADRPSAALEKLKRQLDEAEAAVEARKKPPPETGPRVVGEG
LVIDEWKERREKYLARQQVESVDSLS*
>AT4G11420.1 | EIF3A (EUKARYOTIC TRANSLATION INITIATION FACTOR 3A) translation initiation factor
MANFAKPENALKRADELINVGQKQDALQALHDLITSKRYRAWQKPLEKIMFKYLDLCVDL
KRGRFAKDGLIQYRIVCQQVNVSSLEEVIKHFLHLATDKAEQARSQADALEEALDVDDLE
ADRKPEDLQLSIVSGEKGKDRSDRELVTPWFKFLWETYRTVLEILRNNSKLEALYAMTAH
KAFQFCKQYKRTTEFRRLCEIIRNHLANLNKYRDQRDRPDLSAPESLQLYLDTRFDQLKV
ATELGLWQEAFRSVEDIYGLMCMVKKTPKSSLLMVYYSKLTEIFWISSSHLYHAYAWFKL
FSLQKNFNKNLSQKDLQLIASSVVLAALSIPPFDRAQSASHMELENEKERNLRMANLIGF
NLEPKFEGKDMLSRSALLSELVSKGVLSCASQEVKDLFHVLEHEFHPLDLGSKIQPLLEK
ISKSGGKLSSAPSLPEVQLSQYVPSLEKLATLRLLQQVSKIYQTIRIESLSQLVPFFQFS
EVEKISVDAVKNNFVAMKVDHMKGVVIFGNLGIESDGLRDHLAVFAESLSKVRAMLYPVP
SKASKLAGVIPNLADTVEKEHKRLLARKSIIEKRKEDQERQQLEMEREEEQKRLKLQKLT
EEAEQKRLAAELAERRKQRILREIEEKELEEAQALLEETEKRMKKGKKKPLLDGEKVTKQ
SVKERALTEQLKERQEMEKKLQKLAKTMDYLERAKREEAAPLIEAAYQRRLVEEREFYER
EQQREVELSKERHESDLKEKNRLSRMLGNKEIFQAQVISRRQAEFDRIRTEREERISKII
REKKQERDIKRKQIYYLKIEEERIRKLQEEEEARKQEEAERLKKVEAERKANLDKAFEKQ
RQREIELEEKSRREREELLRGTNAPPARLAEPTVTPVGTTAPAAAAAAAGAPAAPYVPKW
KRQTTEVSGPSAPTSSETDRRSNRGPPPGDDHWGSNRGAAQNTDRWTSNRERSGPPAEGG
DRWGSGPRGSDDRRSTFGSSRPRPTQR*
>AT1G12920.1 | ERF1-2 (EUKARYOTIC RELEASE FACTOR 1-2) translation release factor
MAEEADTNIEIWKIKKLIKGLESARGNGTSMISLIMPPRDQVSRVTKMLGDEYGTASNIK
SRVNRQSVLSAITSAQQRLKLYNKVPTNGLVLYTGTIVNDDGKEKKVTFDFEPFRPINAS
LYLCDNKFHTEALNELLESDDKFGFIVMDGNGTLFGTLSGNTREVLHKFTVDLPKKHGRG
GQSALRFARLRMEKRHNYVRKTAELATQFYINPATSQPNVSGLILAGSADFKTELSQSEL
FDPRLQAKILNVVDVSYGGENGFNQAIELSAEILSNVKFIQEKKLIGKYFEEISQDTGKY
VFGVEDTLKALEMGAIETLIVWENLDINRYELKNSTTGEMVVKHFGKDQESDTSNFHDSE
TNAELEVQEKMPLLEWFANEYKRFGCTLEFVTNKSQEGSQFCRGFGGIGGMLRYQLDMRT
FDELSDTEVYEDSD*
>AT5G66020.1 | ATSAC1B (SUPPRESSOR OF ACTIN 1B) phosphatidylinositol-45-bisphosphate 5-phosphatase
MVSRLKIHSGLRLWEFPDQYVIEPTDGSSASCLDISRLDGSMKLIDQVAECNSLRVPKIR
SIFGVVGMLKLLAGSYLVVVTESESVGSFLGHPIYKINSLKFLPCDHSLENPHEEQKKME
TDDYSRLLSVAERTTGLYFSYEINLTLTAQRLHDLGDESKLLPLWRQAEPRFLWNNYMLE
VLIDNKLDQFLLPVIQGSFHSFQTAIGRDIVDITLIARRCSRRNGTRMWRRGADPDGYVA
NFVETEQIVRMNGYTSSFVQIRGSMPFMWEQIVDLTYKPKFEIVQPEEAARIAERHFLDL
RKKYGSVLAVDLVNKHGGEGRLSERFAGAMQHITGDDVRYLHFDFHHICGHIHFERLAIL
YEQMEDFLEKNGYFLLNEKGEKMKEQLGIVRTNCIDCLDRTNVTQSMIGRKLLELQLKRI
GVFGAEETIRSHQNFDECYKILWANHGDDISIQYSGTPALKGDFVRYGQRTIQGVLQDGW
NALARYYLNNFADGTKQDAIDLVQGHYIVAVSRDMAPVPRKRGLEAVANFPVALTVILIS
FWFATMSVKQVGSGYKHLLFSLVWAGISVAVAALVRANGRIFCNRPSLHKPRS*
>AT1G48160.1 | signal recognition particle 19 kDa protein putative / SRP19 putative
MDSGTINIKKWVVIYPVYINSKKTVAEGRRISVSKSCENPNCIEISDCCKHLKLPSAVEI
DKAYPRDFMQVGRVRVQLKREDGTLLNPAITSRKHLMQKIAELVPRHPERVKKQEAQKAK
KQEPQATTSTSGTSSKSGKGGKKKR*
>AT3G28730.1 | ATHMG (ARABIDOPSIS THALIANA HIGH MOBILITY GROUP) transcription factor
MADGHSFNNISLSGRGGKNPGLLKINSGGIQWKKQGGGKAVEVDRSDIVSVSWTKVTKSN
QLGVKTKDGLYYKFVGFRDQDVPSLSSFFQSSYGKTPDEKQLSVSGRNWGEVDLHGNTLT
FLVGSKQAFEVSLADVSQTQLQGKNDVTLEFHVDDTAGANEKDSLMEISFHIPNSNTQFV
GDENRPPSQVFNDTIVAMADVSPGVEDAVVTFESIAILTPRGRYNVELHLSFLRLQGQAN
DFKIQYSSVVRLFLLPKSNQPHTFVVISLDPPIRKGQTMYPHIVMQFETDTVVESELSIS
DELMNTKFKDKLERSYKGLIHEVFTTVLRWLSGAKITKPGKFRSSQDGFAVKSSLKAEDG
VLYPLEKGFFFLPKPPTLILHDEIDYVEFERHAAGGANMHYFDLLIRLKTDHEHLFRNIQ
RNEYHNLYTFISSKGLKIMNLGGAGTADGVAAVLGDNDDDDAVDPHLTRIRNQAADESDE
EDEDFVMGEDDDGGSPTDDSGGDDSDASEGGVGEIKEKSIKKEPKKEASSSKGLPPKRKT
VAADEGSSKRKKPKKKKDPNAPKRAMSGFMFFSQMERDNIKKEHPGIAFGEVGKVLGDKW
RQMSADDKEPYEAKAQVDKQRYKDEISDYKNPQPMNVDSGNDSDSN*
>AT1G06080.1 | ADS1 (DELTA 9 DESATURASE 1) oxidoreductase
MSLSASEKEENNKKMAADKAEMGRKKRAMWERKWKRLDIVKAFASLFVHFLCLLAPFNFT
WPALRVALIVYTVGGLGITVSYHRNLAHRSFKVPKWLEYFFAYCGLLAIQGDPIDWVSTH
RYHHQFTDSDRDPHSPNEGFWFSHLLWLFDTGYLVEKCGRRTNVEDLKRQWYYKFLQRTV
LYHILTFGFLLYYFGGLSFLTWGMGIGVAMEHHVTCLINSLCHVWGSRTWKTNDTSRNVW
WLSVFSFGESWHNNHHAFESSARQGLEWWQIDISWYIVRFLEIIGLATDVKLPSESQRRR
MAMVR*
>AT1G80410.1 | EMB2753 (EMBRYO DEFECTIVE 2753) binding
MGASLPPKEANLFKLIVKSYETKQYKKGLKAADAILKKFPDHGETLSMKGLTLNCMDRKT
EAYELVRLGVKNDIKSHVCWHVLGLLYRSDREYREAIKCYRNALRIDPDNLEILRDLSLL
QAQMRDLSGFVETRQQLLTLKPNHRMNWIGFAVSQHLNANASKAVEILEAYEGTLEDDYP
PENELIEHTEMILYKVSLLEESGSFDKALEELHKKEPKIVDKLSYKEQEVSLLSKVGRLE
EANKLYRVLLSMNPDNYRYHEGLQKCLGLYSESGQYSSDQIEKLNALYQSLSEQYTRSSA
VKRIPLDFLQDENFKEAVAKYIKPLLTKGVPSLFSDLSSLYDHPRKPDILEQLVVEMKHS
IGTTGSFPGSDVKEPPSTLLWTLFFLAQHYDRRGQYDVALCKIDEAIAHTPTVIDLYSVK
SRIMKHAGDLTAAAALADEARGMDLADRYINSECVKRMLQADQVPLAEKTAVLFTKEGDQ
LNNLHDMQCMWYDLASGDSYFRQGDLGRALKKFLAVEKHYADISEDQFDFHSYCLRKMTL
RSYVDMLKFQDRLHSFPYFHKAAIRAIRCYLKLHDSPKSTAGEDEMSKLAPAQKKKIKKQ
KKAEARAKKEAESKSEESTASGASKSGKRNVKPVDPDPHGQKLIQVEEPMAEASKYLRLL
QKHSPNSLETHLLSFEVNMRKQKFLLAFQAVKQLLKLGAENPDSHRSLVKFFLMTESISA
PTTEAEKLRWRVLEAERPSISQLQNKSLMEANKEFLGRHEDSLVHRAAYAEMLYILDPSK
KTEAIKIIEDSTNKVVQTNEALGQAREWKLKDCIAVHTLLDTVLLDSQAASRWKSRCAEY
FPCSTHFEGKHCSLMPDSVYNSSRKSNENGDTPNHPMGQTELSDGQLEAFKSLSVAT*
>AT4G05330.1 | AGD13 (ARF-GAP domain 13) ARF GTPase activator/ zinc ion binding
MSNYAAGLGKPGSGKRRIRDLLNQPDNRVCADCGASDPKWASANIGVFICLKCCGVHRSL
GTHISKVLSVTLDEWSDEEVDSMIEIGGNASANSIYEAFLPDTCSKPGPDVNHDQRMRFI
RAKYELQEFLKPSLRITSGKGSTKSSAFLTSSLSRKIMDSFRTNSSSQTMFQEGMVEFIG
LLKVTIKKGTNLAIRDMMSSDPYVVLNLGKQKLQTTVMNSNLNPVWNQELMLSVPESYGP
VKLQVYDYDTFSADDIMGEADIDIQPLITSAMAFGDPEMFGDMQIGKWLKSHDNPLIDDS
IINIVDGKVKQEVQIKLQNVESGELELEMEWLPLDQ*
>AT4G22540.2 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT4G22540.2 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT4G22540.2 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT4G22540.1 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MRVKELHPLCCITLESPHGINSQSPEEPVTTALTRSRSLPAKSLTGGSESETVAGILYKW
TNFGKGWRSRWFLLRNGILSYSKIRRPENLNLLSPDDDVRLIGDISGERLSRMDSCSGRR
KQQKTVGIVHLKVSSFRESKSDDRKFYIFTATKTLHLRTDSITDRAAWLQALASTKCIFP
LRSLNGDFSFIPPKDLSISTERLKKRLHEEGMNENLVKECEQIMLSEFSEMHGQVKLLHE
ERTNLLDALRQLEAANLEVGASGKHEFSSLGRGKYSECSTTASSDGKQEFEDVSEEDEPS
FHDTKEFFNEPNIGSESNLAISGHTDIKRRTKLPDPAEKEKGVSLWSMIKDNVGKDLTRV
CLPVYFNEPISSLQKCFEDLEYSYLLDRAYEHGKSGNGLLRALNVAAFAVSGYASTEGRH
CKPFNPLLGETYEADFPEKGIRFFSEKVSHHPTVIACHCEGKGWKFWGDTNLRSKFWGRS
IQVEPVGVLTLEFDDGEVFQWSKVTSTIYNIILGKLYCDHHGVMQIRGNRQYSCTLKFKE
QSILERNPHQVNGFVEDVAGQKAATIFGKWDDSLYYVAGDGINKSKVSDPASNASLLWKR
TKPPPNVTRYNLTSFAITLNELTPGLQEILPPTDSRLRPDQRHLENGEYEKANLEKQRLE
RRQRMSRQLQESGWRPRWFERQGESDTFKYTGGYWEARGHRNWDDCPDIFGEFTEELADA
A*
>AT4G22540.1 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MRVKELHPLCCITLESPHGINSQSPEEPVTTALTRSRSLPAKSLTGGSESETVAGILYKW
TNFGKGWRSRWFLLRNGILSYSKIRRPENLNLLSPDDDVRLIGDISGERLSRMDSCSGRR
KQQKTVGIVHLKVSSFRESKSDDRKFYIFTATKTLHLRTDSITDRAAWLQALASTKCIFP
LRSLNGDFSFIPPKDLSISTERLKKRLHEEGMNENLVKECEQIMLSEFSEMHGQVKLLHE
ERTNLLDALRQLEAANLEVGASGKHEFSSLGRGKYSECSTTASSDGKQEFEDVSEEDEPS
FHDTKEFFNEPNIGSESNLAISGHTDIKRRTKLPDPAEKEKGVSLWSMIKDNVGKDLTRV
CLPVYFNEPISSLQKCFEDLEYSYLLDRAYEHGKSGNGLLRALNVAAFAVSGYASTEGRH
CKPFNPLLGETYEADFPEKGIRFFSEKVSHHPTVIACHCEGKGWKFWGDTNLRSKFWGRS
IQVEPVGVLTLEFDDGEVFQWSKVTSTIYNIILGKLYCDHHGVMQIRGNRQYSCTLKFKE
QSILERNPHQVNGFVEDVAGQKAATIFGKWDDSLYYVAGDGINKSKVSDPASNASLLWKR
TKPPPNVTRYNLTSFAITLNELTPGLQEILPPTDSRLRPDQRHLENGEYEKANLEKQRLE
RRQRMSRQLQESGWRPRWFERQGESDTFKYTGGYWEARGHRNWDDCPDIFGEFTEELADA
A*
>AT4G22540.1 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MRVKELHPLCCITLESPHGINSQSPEEPVTTALTRSRSLPAKSLTGGSESETVAGILYKW
TNFGKGWRSRWFLLRNGILSYSKIRRPENLNLLSPDDDVRLIGDISGERLSRMDSCSGRR
KQQKTVGIVHLKVSSFRESKSDDRKFYIFTATKTLHLRTDSITDRAAWLQALASTKCIFP
LRSLNGDFSFIPPKDLSISTERLKKRLHEEGMNENLVKECEQIMLSEFSEMHGQVKLLHE
ERTNLLDALRQLEAANLEVGASGKHEFSSLGRGKYSECSTTASSDGKQEFEDVSEEDEPS
FHDTKEFFNEPNIGSESNLAISGHTDIKRRTKLPDPAEKEKGVSLWSMIKDNVGKDLTRV
CLPVYFNEPISSLQKCFEDLEYSYLLDRAYEHGKSGNGLLRALNVAAFAVSGYASTEGRH
CKPFNPLLGETYEADFPEKGIRFFSEKVSHHPTVIACHCEGKGWKFWGDTNLRSKFWGRS
IQVEPVGVLTLEFDDGEVFQWSKVTSTIYNIILGKLYCDHHGVMQIRGNRQYSCTLKFKE
QSILERNPHQVNGFVEDVAGQKAATIFGKWDDSLYYVAGDGINKSKVSDPASNASLLWKR
TKPPPNVTRYNLTSFAITLNELTPGLQEILPPTDSRLRPDQRHLENGEYEKANLEKQRLE
RRQRMSRQLQESGWRPRWFERQGESDTFKYTGGYWEARGHRNWDDCPDIFGEFTEELADA
A*
>AT4G22540.3 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT4G22540.3 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT4G22540.3 | ORP2A (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 2A) oxysterol binding / phosphoinositide binding
MNENLVKECEQIMLSEFSEMHGQVKLLHEERTNLLDALRQLEAANLEVGASGKHEFSSLG
RGKYSECSTTASSDGKQEFEDVSEEDEPSFHDTKEFFNEPNIGSESNLAISGHTDIKRRT
KLPDPAEKEKGVSLWSMIKDNVGKDLTRVCLPVYFNEPISSLQKCFEDLEYSYLLDRAYE
HGKSGNGLLRALNVAAFAVSGYASTEGRHCKPFNPLLGETYEADFPEKGIRFFSEKVSHH
PTVIACHCEGKGWKFWGDTNLRSKFWGRSIQVEPVGVLTLEFDDGEVFQWSKVTSTIYNI
ILGKLYCDHHGVMQIRGNRQYSCTLKFKEQSILERNPHQVNGFVEDVAGQKAATIFGKWD
DSLYYVAGDGINKSKVSDPASNASLLWKRTKPPPNVTRYNLTSFAITLNELTPGLQEILP
PTDSRLRPDQRHLENGEYEKANLEKQRLERRQRMSRQLQESGWRPRWFERQGESDTFKYT
GGYWEARGHRNWDDCPDIFGEFTEELADAA*
>AT5G57240.1 | ORP4C (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 4C) oxysterol binding
MKKHVMLVKPFSLEDEKDSENTPPNLIQRILSLFKNVRPGSDLTNFQLPPQMNLARSQLQ
CYGEIVYSFDGHDLLGECSRRDKPIERMKAMVTWYISTLRPLIFGLAPYNPVIGETHHVS
NGHINVLAEQISHHPPVSALHATHEKENVDVLLCQYFTPKFRGAYVDVEVKGKRVVKLLN
HKETYEMNQPKLLMTFLPAMGAHWAGKIVIKCPETGLGAELQLLSDSFLSRFTGNNKRAI
KGKIFESSSRKQLYEISGHWDRTVTAKNTKTGQLEVIYKASENIAKLKTPIVENLQEVSE
SESAVVWGEVSEGIVTNNWEKAREAKRDVEEKQRESLRKRKASGQSWIPKHFSVARTGKD
WDCVPLQPTVPRAPIVVPL*
>AT5G57240.1 | ORP4C (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 4C) oxysterol binding
MKKHVMLVKPFSLEDEKDSENTPPNLIQRILSLFKNVRPGSDLTNFQLPPQMNLARSQLQ
CYGEIVYSFDGHDLLGECSRRDKPIERMKAMVTWYISTLRPLIFGLAPYNPVIGETHHVS
NGHINVLAEQISHHPPVSALHATHEKENVDVLLCQYFTPKFRGAYVDVEVKGKRVVKLLN
HKETYEMNQPKLLMTFLPAMGAHWAGKIVIKCPETGLGAELQLLSDSFLSRFTGNNKRAI
KGKIFESSSRKQLYEISGHWDRTVTAKNTKTGQLEVIYKASENIAKLKTPIVENLQEVSE
SESAVVWGEVSEGIVTNNWEKAREAKRDVEEKQRESLRKRKASGQSWIPKHFSVARTGKD
WDCVPLQPTVPRAPIVVPL*
>AT5G57240.2 | ORP4C (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 4C) oxysterol binding
MKKHVMLVKPFSLEDEKDSENTPPNLIQRILSLFKNVRPGSDLTNFQLPPQMNLARSQLQ
CYGEIVYSFDGHDLLGECSRRDKPIERMKAMVTWYISTLRPLIFGLAPYNPVIGETHHVS
NGHINVLAEQISHHPPVSALHATHEKENVDVLLCQYFTPKFRGAYVDVEVKGKRVVKLLN
HKETYEMNQPKLLMTFLPAMGAHWAGKIVIKCPETGLGAELQLLSDSFLSRFTGNNKRAI
KGKIFESSSRKQLYEISGHWDRTVTAKNTKTGQLEVIYKASENIAKLKTPIVENLQEVSE
SESAVVWGEVSEGIVTNNWEKAREAKRDVEEKQRESLRKRKASGQSWIPKHFSVARTGKD
WDCVPLQPTVPRAPIVVPL*
>AT5G57240.2 | ORP4C (OSBP(OXYSTEROL BINDING PROTEIN)-RELATED PROTEIN 4C) oxysterol binding
MKKHVMLVKPFSLEDEKDSENTPPNLIQRILSLFKNVRPGSDLTNFQLPPQMNLARSQLQ
CYGEIVYSFDGHDLLGECSRRDKPIERMKAMVTWYISTLRPLIFGLAPYNPVIGETHHVS
NGHINVLAEQISHHPPVSALHATHEKENVDVLLCQYFTPKFRGAYVDVEVKGKRVVKLLN
HKETYEMNQPKLLMTFLPAMGAHWAGKIVIKCPETGLGAELQLLSDSFLSRFTGNNKRAI
KGKIFESSSRKQLYEISGHWDRTVTAKNTKTGQLEVIYKASENIAKLKTPIVENLQEVSE
SESAVVWGEVSEGIVTNNWEKAREAKRDVEEKQRESLRKRKASGQSWIPKHFSVARTGKD
WDCVPLQPTVPRAPIVVPL*
>AT4G14390.1 | ankyrin repeat family protein
MDELFVSISSTFSKTSCITDLLLPLELDRIEAQRSTDASHDQQNRTYLPMNIHGSQDFSQ
SGGDGVTPLTGDTESVPEFLTNLRLSDLYAIRGEDVRMIPEVFSKISDGNKECLEKLRSR
GISVARIKSNTGDSILHLAVTWGHLELVKEIVCECPRLLLEQNSSGQTPLHVAAHSGHTT
IVEAFVALVTFSSARLCNEESERMNPYVLKDKDGNTALYYAIEGRYFEMAVCLVNANQDA
PFLGNKYGVSSLFVAINTGDVSLVKAILKIIGNKDLKGKKSNLESKLQGQKSLAHVALVT
QSIAGVLDVILDEYPSLMDERDINGWTCLSLAAHIGYYEGVCNLLERSTKGVYVCDQDGS
FPIHTAAEKGHENIVEEFIKRCPGSKHLLNKLGQNVLHIAAKNGKFWISNMLIINKDTEH
LGVGQDVDGNTPLHLAVMNWHFKSITWLARSSKILKVRNKNGLRARDIAEREVKPHYIFQ
ERWTLALLLYAIHSRGFESVHSLTKPSVPLDPKNNRDYVNTLLLVAALVATMTFAAGFTI
PGGFNSSAPHLGRATLATNPTLFIFLVLDILAMQSSVATIGILIWAQLGDPVLIRSSLHV
ALPLLLFALLCMPLAFLFGVVTAVGHVKWLVVIICIISVLFFSWAIFVLGPHVMLQRSYV
SPKYAGDFLVTFMQYKDIIGLFVSLIKFLFCGCY*